Drug-Induced Intracranial Hypertension: A Systematic Review and Critical Assessment of Drug-Induced Causes

被引:38
|
作者
Tan, Marcus G. [1 ]
Worley, Brandon [1 ]
Kim, Whan B. [1 ]
ten Hove, Martin [2 ]
Beecker, Jennifer [1 ]
机构
[1] Univ Ottawa, Div Dermatol, Ottawa, ON, Canada
[2] Queens Univ, Dept Ophthalmol, Kingston, ON, Canada
关键词
TETRACYCLINE ANTIBIOTICS PRIOR; PSEUDOTUMOR CEREBRI; VITAMIN-A; ISOTRETINOIN; MINOCYCLINE; PERIOD; ADULTS;
D O I
10.1007/s40257-019-00485-z
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Idiopathic intracranial hypertension (IIH) is a condition with increased intracranial pressure of unknown etiology. Its presenting symptoms include persistent headache, pulsatile tinnitus, and visual obscuration. It tends to occur in obese women of childbearing age, and its greatest risk is irreversible loss of vision. Some of the commonly used medications in dermatology, especially those for acne vulgaris, have been associated with IIH. However, the creation of specific risk categories for drugs as a guide for clinicians has never been performed. Objective The aim of this study was to critically assess all published cases of IIH and identify high-risk drugs associated with drug-induced intracranial hypertension (DIIH), to assist dermatologists and other physicians with patient education and monitoring of symptoms of secondary intracranial hypertension. Methods MEDLINE, EMBASE, and Cochrane Review Databases were searched for all cases of IIH thought to be drug-related between January 1900 and June 2019. A total of 5117 articles were identified, and 235 articles were found to be relevant. All cases were assessed to satisfy the modified Dandy criteria for diagnosis of IIH, and the likelihood of each case being a 'definite' adverse drug reaction (ADR) was determined using the Koh algorithm for ADR. An association category (from weakly associated [Category I] to strongly associated [Category V]) was assigned based on the number of cases meeting these two criteria. Results There were 259 verifiable cases of DIIH. Vitamin A derivatives, tetracycline-class antibiotics, recombinant growth hormone, and lithium were found to be most strongly associated with DIIH (Categories IV and V). Corticosteroids were moderately associated with DIIH (Category III). Drugs that were weakly associated with DIIH (Categories I and II) include cyclosporine, progestin-only contraceptives, combined oral contraceptives, second- and third-generation fluoroquinolones, sulfenazone, gonadotropin-releasing hormones and luteinizing hormone-releasing hormone agonist, nalidixic acid, amiodarone, stanozolol, danazol, divalproic acid, sulfasalazine, ketoconazole, and ustekinumab. Conclusion We suggest using the term 'drug-induced intracranial hypertension' (DIIH) and propose a set of diagnostic criteria for DIIH. Our review attempts to identify DIIH-associated drugs based on a strict diagnostic and drug-causality algorithm, then stratify them into appropriate risks categories. This may ultimately assist physicians in counselling patients about the risk of DIIH when prescribing medications and recognizing this uncommon yet sight-threatening condition.
引用
收藏
页码:163 / 172
页数:10
相关论文
共 50 条
  • [41] DRUG-INDUCED DISEASES - DRUG-INDUCED HEMATOLOGICAL DISEASE
    DAWSON, AA
    [J]. BRITISH MEDICAL JOURNAL, 1979, 1 (6172): : 1195 - 1197
  • [42] DRUG-INDUCED DISEASES - DRUG-INDUCED METABOLIC DISEASE
    RICHARDS, P
    [J]. BRITISH MEDICAL JOURNAL, 1979, 1 (6171): : 1128 - 1129
  • [43] Drug-Induced Hepatotoxicity or Drug-Induced Liver Injury
    Pugh, Aaron J.
    Barve, Ashutosh J.
    Falkner, Keith
    Patel, Mihir
    McClain, Craig J.
    [J]. CLINICS IN LIVER DISEASE, 2009, 13 (02) : 277 - +
  • [44] DRUG-INDUCED TRANQUILIZATION VS DRUG-INDUCED AGITATION
    MUSZYNSKI, H
    MAFFETT, ER
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1959, 115 (11): : 1029 - 1030
  • [45] Drug-Induced Hyperthermia Review
    Horseman, Michael
    Panahi, Ladan
    Udeani, George
    Tenpas, Andrew S.
    Verduzco, Rene, Jr.
    Patel, Pooja H.
    Bazan, Daniela Z.
    Mora, Andrea
    Samuel, Nephy
    Mingle, Anne-Cecile
    Leon, Lisa R.
    Varon, Joseph
    Surani, Salim
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (07)
  • [46] DRUG-INDUCED PARKINSONISM - A REVIEW
    MONTASTRUC, JL
    LLAU, ME
    RASCOL, O
    SENARD, JM
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1994, 8 (04) : 293 - 306
  • [47] Drug-Induced Pigmentation: A Review
    Tisack, Aaron
    Mohammad, Tasneem F.
    [J]. DRUGS, 2024, 84 (09) : 1071 - 1091
  • [48] DRUG-INDUCED DISEASES - DRUG-INDUCED NEUROLOGICAL DISEASE
    CRITCHLEY, EMR
    [J]. BRITISH MEDICAL JOURNAL, 1979, 1 (6167): : 862 - 865
  • [49] A review of drug-induced hypernatraemia
    Liamis, George
    Milionis, Haralampos J.
    Elisaf, Moses
    [J]. CLINICAL KIDNEY JOURNAL, 2009, 2 (05): : 339 - 346
  • [50] DRUG-INDUCED DISEASES - DRUG-INDUCED SKIN DISEASES
    HARDIE, RA
    SAVIN, JA
    [J]. BRITISH MEDICAL JOURNAL, 1979, 1 (6168): : 935 - 937